Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1962 Aug;19(1):74–84. doi: 10.1111/j.1476-5381.1962.tb01428.x

Mechanism of action of guanethidine

K Ka̧dzielawa
PMCID: PMC1482245  PMID: 14453004

Abstract

The early hypotensive action of intravenous guanethidine in rabbits, rats and cats anaesthetized with urethane is reversed after pretreatment with iproniazid. The fall in blood pressure following injection of guanethidine in rabbits is reduced after previous administration of reserpine. Reserpine, like adrenalectomy and splenectomy, suppresses the early pressor effect of guanethidine in cats anaesthetized with chloralose. Guanethidine inhibits the action of tyramine and nicotine, but potentiates the effect of noradrenaline on isolated rabbit atria. Guanethidine is also a weak inhibitor of monoamine oxidase activity. The results are discussed and compared with those shown by reserpine. It is concluded that the early effects of guanethidine are mainly due to the release of endogenous catechol amines.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AZARNOFF D. L., BURN J. H. Effect of noradrenaline on the action of nicotine and tyramine on isolated atria. Br J Pharmacol Chemother. 1961 Jun;16:335–343. doi: 10.1111/j.1476-5381.1961.tb01093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BARTLET A. L. The pressor action of guanethidine in the spinal cat. J Pharm Pharmacol. 1962 Feb;14:91–95. doi: 10.1111/j.2042-7158.1962.tb11058.x. [DOI] [PubMed] [Google Scholar]
  3. BEJRABLAYA D., BURN J. H., WALKER J. M. The action of sympathomimetic amines on heart rate in relation to the effect of reserpine. Br J Pharmacol Chemother. 1958 Dec;13(4):461–466. doi: 10.1111/j.1476-5381.1958.tb00238.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BENFEY B. G., GREEFF K. Interactions of sympathomimetic drugs and their antagonists on the isolated atrium. Br J Pharmacol Chemother. 1961 Oct;17:232–235. doi: 10.1111/j.1476-5381.1961.tb01283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BOGAERT M., DE SCHAEPDRYVER A. F., DE VLEESCHHOUWER G. R. On the pharmacology of guanethidine. Arch Int Pharmacodyn Ther. 1961 Nov 1;134:224–236. [PubMed] [Google Scholar]
  6. BURN J. H. A new view of adrenergic nerve fibres, explaining the action of reserpine, bretylium, and guanethidine. Br Med J. 1961 Jun 10;1(5240):1623–1627. doi: 10.1136/bmj.1.5240.1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BURN J. H., RAND M. J. Action of nicotine on the heart. Br Med J. 1958 Jan 18;1(5063):137–139. doi: 10.1136/bmj.1.5063.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. BURN J. H., RAND M. J. The action of sympathomimetic amines in animals treated with reserpine. J Physiol. 1958 Dec 4;144(2):314–336. doi: 10.1113/jphysiol.1958.sp006104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BURN J. H., RAND M. J. The cause of the supersensitivity of smooth muscle to noradrenaline after sympathetic degeneration. J Physiol. 1959 Jun 23;147(1):135–143. doi: 10.1113/jphysiol.1959.sp006228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. BUTTERFIELD J. L., RICHARDSON J. A. Acute effects of guanethidine on myocardial contractility and catecholamine levels. Proc Soc Exp Biol Med. 1961 Feb;106:259–262. doi: 10.3181/00379727-106-26303. [DOI] [PubMed] [Google Scholar]
  11. CASS R., KUNTZMAN R., BRODIE B. B. Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med. 1960 Apr;103:871–872. doi: 10.3181/00379727-103-25702. [DOI] [PubMed] [Google Scholar]
  12. CASS R., SPRIGGS T. L. Tissue amine levels and sympathetic blockade after guanethidine and bretylium. Br J Pharmacol Chemother. 1961 Dec;17:442–450. doi: 10.1111/j.1476-5381.1961.tb01131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. CHESSIN M., KRAMER E. R., SCOTT C. C. Modifications of the pharmacology of reserpine and serotonin by iproniazid. J Pharmacol Exp Ther. 1957 Apr;119(4):453–460. [PubMed] [Google Scholar]
  14. CREASEY N. H. Factors which interfere in the manometric assay of monoamine oxidase. Biochem J. 1956 Sep;64(1):178–183. doi: 10.1042/bj0640178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. DAY M. D., RAND M. J. Effect of guanethidine in revealing cholinergic sympathetic fibres. Br J Pharmacol Chemother. 1961 Oct;17:245–260. doi: 10.1111/j.1476-5381.1961.tb01285.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. DRESSE A., SODOYEZ J. C. [Effect of guanethidine on arterial pressure and on the uterus of the rat]. C R Seances Soc Biol Fil. 1960;154:2399–2401. [PubMed] [Google Scholar]
  17. FLECKENSTEIN A., BURN J. H. The effect of denervation on the action of sympathomimetic amines on the nictitating membrane. Br J Pharmacol Chemother. 1953 Mar;8(1):69–78. doi: 10.1111/j.1476-5381.1953.tb00754.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. GILLIS C. N., NASH C. W. The initial pressor actions of bretylium tosylate and guanethidine sulfate and their relation to release of catecholamines. J Pharmacol Exp Ther. 1961 Oct;134:1–7. [PubMed] [Google Scholar]
  19. HERTTING G., AXELROD J., PATRICK R. W. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br J Pharmacol Chemother. 1962 Feb;18:161–166. doi: 10.1111/j.1476-5381.1962.tb01159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LEUSEN I., VERBEKE R. The action of sympathomimetic amines on the myocardium after pretreatment with reserpine. Arch Int Pharmacodyn Ther. 1960 Apr 1;125:246–247. [PubMed] [Google Scholar]
  21. MAXWELL R. A., MULL R. P., PLUMMER A. J. [2-Octahydro-1-azocinyl)-ethyl]-guanidine sulfate (CIBA 5864-SU), a new synthetic antithypertensive agents]. Experientia. 1959 Jul 15;15:267–267. doi: 10.1007/BF02158076. [DOI] [PubMed] [Google Scholar]
  22. MAXWELL R. A., PLUMMER A. J., PAYTAS J. J., ROSS S. D., DANIEL A. I. Influence of adrenergic blockade and an amine oxidase inhibitor on reserpine hypotension. Proc Soc Exp Biol Med. 1957 Jul;95(3):539–541. doi: 10.3181/00379727-95-23281. [DOI] [PubMed] [Google Scholar]
  23. MAXWELL R. A., PLUMMER A. J., SCHNEIDER F., POVALSKI H., DANIEL A. I. Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864). J Pharmacol Exp Ther. 1960 Jan;128:22–29. [PubMed] [Google Scholar]
  24. MAXWELL R. A., POVALSKI H., PLUMMER A. J. A differential effect of reserpine on pressor amine activity and its relationship to other agents producing this effect. J Pharmacol Exp Ther. 1959 Feb;125(2):178–183. [PubMed] [Google Scholar]
  25. MCCUBBIN J. W., KANEKO Y., PAGE I. H. The peripheral cardiovascular actions of guanethidine in dogs. J Pharmacol Exp Ther. 1961 Mar;131:346–354. [PubMed] [Google Scholar]
  26. PAGE I. H., DUSTAN H. P. A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine). J Am Med Assoc. 1959 Jul 11;170(11):1265–1271. doi: 10.1001/jama.1959.03010110013003. [DOI] [PubMed] [Google Scholar]
  27. PEPEU G., ROBERTS M., SCHANBERG S., GIARMAN N. J. Differential action of iproniazid (Marsilid) and betaphenyl-isopropylhydrazine (Catron) on isolated atria. J Pharmacol Exp Ther. 1961 May;132:131–138. [PubMed] [Google Scholar]
  28. POVALSKI H. J., GOLDSMITH E. D. Effect of methylphenidate on cardiovascular actions of pressor amines. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:717–721. doi: 10.3181/00379727-101-25072. [DOI] [PubMed] [Google Scholar]
  29. REUSE J. J., BERGMANN F. [Pharmacodynamic properties of guanethidine]. C R Seances Soc Biol Fil. 1960;154:1536–1539. [PubMed] [Google Scholar]
  30. SANAN S., VOGT M. Effect of drugs on the noradrenaline content of brain and peripheral tissues and its significance. Br J Pharmacol Chemother. 1962 Feb;18:109–127. doi: 10.1111/j.1476-5381.1962.tb01155.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES